Ups and downs of conducting a national representative survey on hypertension during pandemic time: main results of SEPHAR IV

Author:

Dorobantu Maria12,Cojocaru Cosmin13,Stanciulescu Laura3,Pop Calin4,Bala Cornelia5,Benedek Theodora6,Parepa Irinel7,Lighezan Daniel8,Darabont Roxana19,Darabantiu Dan10,Mitu Florin11,Gheorghita Valeriu112,Scafa-Udriste Alexandru13,Gheorghe-Fronea Oana-Florentina13

Affiliation:

1. Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy

2. Romanian Academy

3. Cardiology Department, Clinical Emergency Hospital, Bucharest

4. Emergency Clinical County Hospital of Baia Mare, Baia Mare

5. Faculty of Medicine, “Iuliu Hateganu” University of Medicine and Pharmacy, Cluj-Napoca

6. Cardiology Department, County Clinical Emergency Hospital, Targu Mures

7. Cardiology Department, “Ovidius” University Constanta, Constanta

8. Faculty of Medicine, “Victor Babeş” University of Medicine and Pharmacy, Timisoara

9. Cardiology Department, University Emergency Hospital Bucharest, Bucharest

10. Cardiology Department, County Hospital Arad, Arad

11. Cardiology Department, Clinical Rehabilitation Hospital, Iaşi

12. Central Military Emergency University Hospital Dr Carol Davila, Bucharest, Romania

Abstract

Objectives: This national representative survey sought to assess hypertension's prevalence, awareness, treatment and control in Romania. Methods: A representative sample (by age, sex and residence) of 1477 Romanian adults (51.19 ± 16.61 years, range 18–80 years, 59.9% women) was multimodally evaluated during two study visits. Hypertension was defined as SBP at least 140 mmHg and/or DBP at least 90 mmHg or previously diagnosed hypertension, regardless of BP. Awareness was defined by knowledge of previous hypertension diagnosis or of current use of antihypertensive treatment. Treatment was defined by antihypertensive medication taken at least 2 weeks prior to enrolment. Control was defined as SBP less than 140 mmHg and DBP less than 90 mmHg at both visits in treated hypertensive patients. Results: Hypertension prevalence was 46% (n = 680) consisting of 81.02% (n = 551) known hypertensive patients and 18.98% (n = 129) newly diagnosed hypertensive patients. Awareness, treatment and control of hypertension were: 81% (n = 551), 83.8% (n = 462) and 39.2% (n = 181). Conclusion: Despite numerous pandemic-related obstacles in conducting a national survey, SEPHAR IV updates hypertension epidemiological data of a high-cardiovascular-risk Eastern-European population. This study confirms previous predictions of hypertension prevalence, treatment and control, which remain unfavourable because of unsatisfactory control of promoting factors.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3